Variation of Minimum Clinically Important Difference by Age, Gender, Baseline Disability, and Change of Direction in Adult Spinal Deformity Population: Is It a Constant Value?


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
02 2021
Historique:
received: 27 09 2020
revised: 20 11 2020
accepted: 21 11 2020
pubmed: 2 12 2020
medline: 6 7 2021
entrez: 1 12 2020
Statut: ppublish

Résumé

The minimum clinically important difference (MCID), an important concept to evaluate the effectiveness of treatments, might not be a single "magical" constant for any given health-related quality of life (HRQoL) scale. Thus, we analyzed the effects of various factors on MCIDs for several HRQoL measures in an adult spinal deformity population. Surgical and nonsurgical patients from a multicenter adult spinal deformity database who had completed pretreatment and 1-year follow-up questionnaires (Core Outcome Measures Index [COMI], Oswestry Disability Index [ODI], Medical Outcomes Study 36-item short-form questionnaire, 22-item Scoliosis Research Society Outcomes questionnaire, and an anchor question of "back health"-related change during the previous year) were evaluated. The MCIDs for each HRQoL measure were calculated using an anchor-based method and latent class analysis for the overall population and subpopulations stratified by age, gender, and baseline scores (ODI and COMI) separately for patients with positive versus negative perceptions of change. Patients with a baseline ODI score of <20, 20-40, and >40 had an MCID of 2.24, 11.35, and 26.57, respectively. Similarly, patients with a baseline COMI score of <2.75, 2.8-5.4, and >5.4 had an MCID of 0.59, 1.38, and 3.67 respectively. The overall MCID thresholds for deterioration and improvement were 0.27 and 2.62 for COMI, 2.23 and 14.31 for ODI, and 0.01 and 0.71 for 22-item Scoliosis Research Society Outcomes questionnaire, respectively. The results from the present study have demonstrated that MCIDs change in accordance with the baseline scores and direction of change but not by age or gender. The MCID, in its current state, should be considered a concept rather than a constant.

Sections du résumé

BACKGROUND
The minimum clinically important difference (MCID), an important concept to evaluate the effectiveness of treatments, might not be a single "magical" constant for any given health-related quality of life (HRQoL) scale. Thus, we analyzed the effects of various factors on MCIDs for several HRQoL measures in an adult spinal deformity population.
METHODS
Surgical and nonsurgical patients from a multicenter adult spinal deformity database who had completed pretreatment and 1-year follow-up questionnaires (Core Outcome Measures Index [COMI], Oswestry Disability Index [ODI], Medical Outcomes Study 36-item short-form questionnaire, 22-item Scoliosis Research Society Outcomes questionnaire, and an anchor question of "back health"-related change during the previous year) were evaluated. The MCIDs for each HRQoL measure were calculated using an anchor-based method and latent class analysis for the overall population and subpopulations stratified by age, gender, and baseline scores (ODI and COMI) separately for patients with positive versus negative perceptions of change.
RESULTS
Patients with a baseline ODI score of <20, 20-40, and >40 had an MCID of 2.24, 11.35, and 26.57, respectively. Similarly, patients with a baseline COMI score of <2.75, 2.8-5.4, and >5.4 had an MCID of 0.59, 1.38, and 3.67 respectively. The overall MCID thresholds for deterioration and improvement were 0.27 and 2.62 for COMI, 2.23 and 14.31 for ODI, and 0.01 and 0.71 for 22-item Scoliosis Research Society Outcomes questionnaire, respectively.
CONCLUSIONS
The results from the present study have demonstrated that MCIDs change in accordance with the baseline scores and direction of change but not by age or gender. The MCID, in its current state, should be considered a concept rather than a constant.

Identifiants

pubmed: 33259972
pii: S1878-8750(20)32509-2
doi: 10.1016/j.wneu.2020.11.124
pii:
doi:

Substances chimiques

Analgesics 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1171-e1176

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Sinan Bahadır (S)

ARTES Spine Center, Acibadem Ankara Hospital, Ankara, Turkey.

Selcen Yuksel (S)

Department of Biostatistics, Yildirim Beyazit University, Ankara, Turkey.

Selim Ayhan (S)

ARTES Spine Center, Acibadem Ankara Hospital, Ankara, Turkey.

Vugar Nabi (V)

ARTES Spine Center, Acibadem Ankara Hospital, Ankara, Turkey.

Alba Vila-Casademunt (A)

Department of Orthopedic Surgery, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Ibrahim Obeid (I)

Department of Orthopedic Surgery, Bordeaux University Hospital, Bordeaux, France.

Francisco Javier Sanchez Perez-Grueso (FJ)

Department of Orthopedic Surgery, Hospital Universitari La Paz, Madrid, Spain.

Emre Acaroglu (E)

Department of Orthopedic Surgery, Ankara Spine Center, Ankara, Turkey. Electronic address: acaroglue@gmail.com.
Department of Orthopedic Surgery, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH